Selective HSP90β Inhibition Disrupts SREBP1-Associated Metabolic Signaling and Suppresses Ovarian Cancer Progression: A Pilot Study
Ovarian cancer progression is supported by metabolic interactions between tumor cells and the adipocyte-rich peritoneal microenvironment, which can be further altered by obesity. Sterol regulatory element-binding protein 1 (SREBP1), a master regulator of lipid metabolism, represents a potential therapeutic target in this setting. Because heat shock protein 90 (HSP90) regulates SREBP1 stability and processing, we investigated whether selective inhibition of HSP90β with NDNB25 could disrupt SREBP1-associated metabolic signaling and suppress ovarian cancer progression. In a diet-induced obesity model, NDNB25 significantly reduced overall tumor burden in both low-fat and high-fat diet mice and decreased adipocyte area within intra-tumoral, peri-tumoral, and surrounding visceral adipose regions. In human and murine ovarian cancer cells, NDNB25 altered SREBP1 protein abundance and produced concentration-dependent effects on cell viability. Transcriptomic analysis demonstrated negative enrichment of an SREBP1-associated lipogenic program across OVCAR5, OVCAR8, and ID8 cells, together with broader remodeling of lipid-metabolic, inflammatory, and tumor-associated signaling pathways. Analysis of gene expression data from human ovarian tumors further demonstrated a positive association between HSP90AB1 expression and SREBP1-associated lipogenic signaling. Collectively, these findings demonstrate that selective HSP90β inhibition suppresses ovarian cancer progression across lean and obese host environments and induces broad transcriptional remodeling of metabolic and tumor-associated pathways, including SREBP1-associated lipid metabolism, supporting HSP90β as a potential therapeutic target for metabolically adapted ovarian cancer.
Authors
- Wanrui Wang (ORCID: https://orcid.org/0000-0001-9757-7364)
- Gena M. Dominique
- Mary Sharon Stack (ORCID: https://orcid.org/0000-0003-4563-7390)
- Jing Yang (ORCID: https://orcid.org/0000-0003-2733-8629)
- Brian S. J. Blagg (ORCID: https://orcid.org/0000-0002-6200-3480)
- Emily Cronberger
- JEFFREY JOHNSON
- Terin D’Amico
- Grace Wikenheiser (ORCID: https://orcid.org/0009-0006-5721-428X)
- Brighton Strasiotto
- Theresa Kerker
- Caitlyn Breslin
- Maia Oh
- Ellen Crotzer
- Sanket Mishra
Institutions
- University of Notre Dame (US)
- Mike and Josie Harper Cancer Research Institute (US)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3390/ijms272210460
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Walther Cancer Foundation
- Mike and Josie Harper Cancer Research Institute